Filter Results
:
(593)
Show Results For
-
All HBS Web
(1,028)
- People (4)
- News (251)
- Research (593)
- Events (7)
- Multimedia (25)
- Faculty Publications (383)
Show Results For
-
All HBS Web
(1,028)
- People (4)
- News (251)
- Research (593)
- Events (7)
- Multimedia (25)
- Faculty Publications (383)
Sort by
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,...
View Details
Keywords:
Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from...
View Details
Keywords:
Martha Lagace
- 12 May 2009
- First Look
First Look: May 12, 2009
their practices. Sermo earns revenue by charging clients who would value early information regarding the effectiveness of new drugs and medical devices-investment managers, pharmaceutical companies, and regulatory authorities. Clients...
View Details
Keywords:
Martha Lagace
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
The book Capitalism at Risk first appeared in 2011. The problems it identified with social inequality, global trade strife, and environmental degradation have only accelerated by 2020. The new edition of Capitalism at Risk, subtitled How Business Can Lead, is expanded...
View Details
Keywords:
by Martha Lagace
- 22 Mar 2011
- First Look
First Look: March 22
successful convenience foods business to more countries. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511070-PDF-ENG PureCircle David E. Bell and Aldo SesiaHarvard Business School Case 510-032 In December 2008, the U.S. Food and View Details
Keywords:
Sean Silverthorne
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details
- 12 Feb 2008
- First Look
First Look: February 12, 2007
stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was highly undervalued due to poor management. After gaining board...
View Details
Keywords:
Martha Lagace
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest...
View Details
Keywords:
Sean Silverthorne
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70...
View Details
Keywords:
Martha Lagace
- 21 Apr 2009
- First Look
First Look: April 21, 2009
Industry Location Author:Arthur A. Daemmrich Abstract A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a...
View Details
Keywords:
Martha Lagace
- 24 Jul 2007
- First Look
First Look: July 24, 2007
the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. Purchase this case:...
View Details
Keywords:
Martha Lagace
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
developed by the Food and Drug Administration (FDA), they were able to tell which companies were competitors in the same patient application areas (such as cardiology, oncology, or urology) and product classes. Then, using commercial...
View Details
- 25 Aug 2015
- First Look
First Look Tuesday
to examine the phenomena in the context of health. In particular, we examine how an individual's prior experiences and the experiences of those around them alter the operational decisions that the individual makes. We draw on an exogenous announcement of negative news...
View Details
- 05 Nov 2007
- Research & Ideas
The Changing Face of American Innovation
on? Are they concentrated in a specific industry or business type? A: Inventors can file for patents in many technology fields, ranging from chemicals and drugs to computer software to agricultural machinery. Immigrant contributions are...
View Details
- 25 Oct 2016
- First Look
October 25, 2016
insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and...
View Details
Keywords:
Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular...
View Details
Keywords:
Martha Lagace
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging...
View Details
Keywords:
Sean Silverthorne
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
A: There is some heartening progress. The word is out among retailers about the under-served market in inner cities. Drug chains, such as Walgreen's, and many other retailers, such as Home Depot, are pursuing this opportunity to good...
View Details
Keywords:
by Sean Silverthorne
- 04 Aug 2009
- First Look
First Look: August 4
to second-line drug regimens, 3.8% had died, and only one patient had been lost to follow up. A costing analysis done by the Clinton HIV/AIDS Initiative suggested that the model could feasibly be spread to other districts. Dr. Agnes...
View Details
Keywords:
Martha Lagace
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is...
View Details